Abstract:
1-Chloro- or 1-fluoro- derivatives of 5H-dibenzo(a, d)cycloheptenes and 1-chloro- or 1-fluoro- derivatives of 10,11dihydro-5H-dibenzo(a,d)cycloheptenes having, at position 5, a basic exocyclic side chain of the formula
wherein R1 is hydrogen or methyl, and intermediates therefor are prepared by alternate procedures. The described end-products are useful, for example, as psychopharmacological antidepressants.
Abstract:
PLEIADENES SUBSTITUTED AT THE 7-POSITION, E.G. 1,2,3,7TETRAHYDRO-7-(1-METHYL-4-PIPERIDYL)PLEIADENE AND 1,2,3, 7,12,12A-HEXAHYDRO-7-(1 - METHYL-4-PIPERIDYL)PLEIADEN-7OL, AND DIBENZOHEPTALENES SUBSTITUTED AT THE 8-POSITION, E.G. 1,2,3,4-TETRAHYDRO-8 - (1-METHYL-4-PIPERIDYL)-8H-DIBENZO(B,EF)HEPTALENE, PREPARED FROM A CORRESPONDING KETONE AND GRIGNARD REAGENT, ARE USEFUL AS CENTRAL NERVOUS SYSTEM STIMULTANTS.
Abstract:
WHEREIN R IS A HYDROGEN, METHYL, OR HALOGEN; N IS ZERO OR ONE AND R1, R2, AND R3 ARE HYDROCARBON RADICALS AND R1 AND R2 CAN BE COMBINED TO FORM A HETEROCYLIC RING WITH THE NITROGEN.
CH2=C(-R)-C6H4-(CH2)N-CO-N(-)-N(+)(-R1)(-R2)-R3
VINYL AROMATIC AMINIMIDES ARE PREPARED FROM VINYL AROMATIC ACIDS OR DERIVATIVES THEREOF. THE VINYL AROMATIC AMINIMIDE CAN BE HOMOPOLYMERIZED AND COPOLYMERIZED TO RESULT IN FUNCTIONAL GROUP-CONTAINING POLYMERIC PRODUCTS CAPABLE OF THERMOSETTING. THE VINYL AROMATIC AMINIMIDES HAVE THE GENERAL FORMULA
Abstract:
Pleiadenes substituted at the 7-position, e.g. 1,2,3,7tetrahydro-7(1-methyl-4-piperidyl)pleiadene and 1,2,3,7,12,12a hexahydro-7-(1-methyl-4-piperidyl)pleiaden-7-ol, and dibenzoheptalenes substituted at the 8-position, e.g. 1,2,3,4tetrahydro-8-(1-methyl-4-piperidyl)-8H-dibenzo(b,ef)heptalene, prepared from a corresponding ketone and Grignard reagent, are useful as anti-convulsants.
Abstract:
Compounds of formula I a process for preparation of compounds of formula I; precursor compounds of formula II a process for preparation of precursor compounds of formula II; compounds of formula III a process for the preparation of compounds of formula IV from compounds of formula III and the use of compounds of formula I for the preparation of compounds of formula IV.
Abstract:
Compounds of formula I a process for preparation of compounds of formula I; precursor compounds of formula II a process for preparation of precursor compounds of formula II; compounds of formula III a process for the preparation of compounds of formula IV from compounds of formula III and the use of compounds of formula I for the preparation of compounds of formula IV.
Abstract:
The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).